Yr Athro Andrew Finlay

2021

• Abdelrazik, Y. T.et al. 2021. Clinical experience and psychometric properties of the Cardiff Acne Disability Index (CADI). British Journal of Dermatology 185(4), pp. 711-724. (10.1111/bjd.20391)
• Stuart, B.et al. 2021. Topical preparations for the treatment of mild-to-moderate acne vulgaris: systematic review and network meta-analysis. British Journal of Dermatology 185(3), pp. 512-525. (10.1111/bjd.20080)
• Chernyshov, P.et al. 2021. Quality of life measurement in alopecia areata. Position statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient Oriented Outcomes. Journal of the European Academy of Dermatology and Venereology 35(8), pp. 1614-1621. (10.1111/jdv.17370)
• Shah, R.et al. 2021. Family reported outcomes, an unmet need in the management of a patient's disease: appraisal of the literature. Health and Quality of Life Outcomes 19, article number: 194. (10.1186/s12955-021-01819-4)
• Finlay, A. Y.et al. 2021. Why we should abandon the misused descriptor "erythema". British Journal of Dermatology (10.1111/bjd.20660)
• Brittain, E.et al. 2021. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): major impact on lives of both patients and family members. Medicina 57(1), article number: 43. (10.3390/medicina57010043)
• Chernyshov, P. V.et al. 2021. Quality of life in hidradenitis suppurativa: an update. International Journal of Environmental Research and Public Health 18(11), article number: 6131. (10.3390/ijerph18116131)
• Shah, R.et al. 2021. Measuring the impact of COVID-19 on the quality of life of the survivors, partners and family members: a cross-sectional international online survey. BMJ Open 11(5), article number: e047680. (10.1136/bmjopen-2020-047680)
• Finlay, A. Y. 2021. Publishing addiction: a behavioural disorder with specific characteristics. British Journal of Dermatology 184(2), pp. 338-339. (10.1111/bjd.19500)
• Finlay, A.et al. 2021. Methods to improve quality of life, beyond medicines. position statement of the European Academy of Dermatology and Venereology task force on quality of life and patient oriented outcomes. Journal of the European Academy of Dermatology and Venereology 35(2), pp. 318-328. (10.1111/jdv.16914)
• Wójcik, E.et al. 2021. Major life changing decision profile: Creation of the Polish language version. Dermatologic Therapy 34(1), article number: e14568. (10.1111/dth.14568)

2020

• Chernyshov, P.et al. 2020. Position statement of the European Academy of Dermatology and Venereology task force on quality of life and patient oriented outcomes on quality of life issues in dermatologic patients during the COVID-19 pandemic. Journal of the European Academy of Dermatology and Venereology 34(8), pp. 1666-1671. (10.1111/jdv.16720)
• Warren, R. B.et al. 2020. Secukinumab for patients failing previous tumour necrosis factor‐α inhibitor therapy: results of a randomized open‐label study (SIGNATURE). British Journal of Dermatology 183(1), pp. 60-70. (10.1111/bjd.18623)
• Ali, F., Vyas, J. and Finlay, A. Y. 2020. Counting the burden: atopic dermatitis and health-related quality of life. Acta Dermato-Venereologica 100(12), article number: adv00161. (10.2340/00015555-3511)
• Dalgard, F. J.et al. 2020. Itch and mental health in dermatological patients across Europe: a cross-sectional study in 13 countries. Journal of Investigative Dermatology 140(3), pp. 568-573. (10.1016/j.jid.2019.05.034)
• Titeca, G.et al. 2020. "The psychosocial burden of alopecia areata and androgenetica": A cross-sectional multicenter study among dermatological out-patients in 13 European Countries. Journal of the European Academy of Dermatology and Venereology 34(2), pp. 406-411. (10.1111/jdv.15927)

2019

• Ali, F.et al. 2019. Validation of the electronic Psoriasis Area and Severity Index application: establishing measurement equivalence. Journal of The American Academy of Dermatology 81(6), pp. 1439-1441. (10.1016/j.jaad.2019.04.073)
• Finlay, A. 2019. Assessing and scoring life quality. In: Harper's Textbook of Pediatric Dermatology. Wiley
• Manolache, L. and Finlay, A. 2019. Why use an allergy-based quality of life measure in childhood atopic eczema. British Journal of Dermatology 181(2), pp. 240-241. (10.1111/bjd.18157)
• Anstey, A. V. and Finlay, A. Y. 2019. Dermatology outpatient care in the UK: modernising services requires patients as our partners. British Journal of Dermatology 180(5), pp. 968-970. (10.1111/bjd.17688)
• Chernyshov, P.et al. 2019. Quality of life measurement in skin cancer patients: literature review and position paper of the European Academy of Dermatology and venereology task forces on quality of life and patient oriented outcomes, melanoma and non‐melanoma skin cancer. Journal of the European Academy of Dermatology and Venereology 33(5), pp. 816-827. (10.1111/jdv.15487)
• Finlay, A. 2019. Pioneers in dermatology and venereology: an interview with Prof. Andrew Finlay. Journal of the European Academy of Dermatology and Venereology 33(4), pp. 633-636. (10.1111/jdv.15550)
• Strober, B. E.et al. 2019. Clinical goals and barriers to effective psoriasis care. Dermatology and Therapy 9(1), pp. 5-18. (10.1007/s13555-018-0279-5)
• Schut, C.et al. 2019. Occurrence, chronicity and intensity of itch in a clinical consecutive sample of patients with skin diseases: a multi-centre study in 13 European countries. Acta Dermato-Venereologica 99(2), pp. 146-151. (10.2340/00015555-3040)
• Brenaut, E.et al. 2019. The self-assessed psychological comorbidities of prurigo in European patients: a multicentre study in 13 countries. Journal of the European Academy of Dermatology and Venereology 33(1), pp. 157-162. (10.1111/jdv.15145)
• Finlay, A. Y. and Anstey, A. V. 2019. Dermatology inpatient care in the U.K.: rarely possible, hard to defend but occasionally essential. British Journal of Dermatology 180(3), pp. 440-442. (10.1111/bjd.17501)

2018

• Finlay, A. Y. and Sampogna, F. 2018. What do scores mean? informed interpretation and clinical judgement are needed. British Journal of Dermatology 179(5), pp. 1021-1022. (10.1111/bjd.17028)
• Dalgard, F. J.et al. 2018. Dermatologists across Europe underestimate depression and anxiety: results from 3635 dermatological consultations. British Journal of Dermatology 179(2), pp. 464-470. (10.1111/bjd.16250)
• Ali, F., Salek, M. S. and Finlay, A. 2018. Two minimal clinically important difference (2MCID): A new twist on an old concept. Acta Dermato Venereologica 98(7), pp. 715-717. (10.2340/00015555-2894)
• Stull, D. E.et al. 2018. Differential effects of secukinumab vs. ustekinumab for treatment of psoriasis on quality of life, work productivity and activity impairment: a structural equation modelling analysis. British Journal of Dermatology 178(6), pp. 1297-1307. (10.1111/bjd.16366)
• Marron, S. E.et al. 2018. The psychosocial burden of hand eczema: Data from a European dermatological multicentre study. Contact Dermatitis (10.1111/cod.12973)
• Chernyshov, P. V.et al. 2018. Quality of life measurement in acne. Position paper of the European Academy of Dermatology and Venereology (EADV) task forces on quality of life and patient oriented outcomes (QoL and PO) and acne, rosacea and hidradenitis suppurativa (ARHS). Journal of the European Academy of Dermatology and Venereology 32(2), pp. 194-208. (10.1111/jdv.14585)
• Basra, M. K. A.et al. 2018. Conceptualisation, development and validation of T-QoL© (Teenagers' Quality of Life): a patient-focused measure to assess quality of life of adolescents with skin diseases. British Journal of Dermatology 178(1), pp. 161-175. (10.1111/bjd.15853)
• Harun, A.et al. 2018. How to train to discharge a dermatology outpatient: A review. Dermatology 233(4), pp. 260-267. (10.1159/000479060)

2017

• Finlay, A. 2017. Real-world effect of biologics on quality of life in psoriasis. British Journal of Dermatology 177(5), pp. 1164-1165. (10.1111/bjd.15945)
• Ali, F. M.et al. 2017. Mapping of the DLQI scores to EQ-5D utility values using ordinal logistic regression. Quality of Life Research 26, pp. 3025-3034. (10.1007/s11136-017-1607-4)
• Ali, F. M.et al. 2017. Comparison of the paper-based and electronic versions of the Dermatology Life Quality Index (DLQI): evidence of equivalence. British Journal of Dermatology 177(5), pp. 1306-1315. (10.1111/bjd.15314)
• Atwan, A.et al. 2017. Dermatology life quality index (DLQI) as a psoriasis referral triage tool. British Journal of Dermatology 177(4), pp. e136-e137. (10.1111/bjd.15446)
• Finlay, A. Y.et al. 2017. Omalizumab substantially improves dermatology-related quality of life in patients with chronic spontaneous urticaria. Journal of the European Academy of Dermatology and Venereology 31(10), pp. 1715-1721. (10.1111/jdv.14384)
• Sampogna, F.et al. 2017. Measuring the impact of dermatological conditions on family and caregivers: a review of dermatology-specific instruments. Journal of the European Academy of Dermatology and Venereology 31(9), pp. 1429-1439. (10.1111/jdv.14288)
• Lesner, K.et al. 2017. Determinants of psychosocial health in psoriatic patients: A multi­national study. Acta Dermato-Venereologica 97(10), pp. 1182-1188. (10.2340/00015555-2760)
• Higaki, Y.et al. 2017. Japanese version of the family dermatology life quality index: translation and validation. The Journal of Dermatology 44(8), pp. 914-919. (10.1111/1346-8138.13831)
• Finlay, A. 2017. Broader concepts of quality of life measurement, encompassing validation. Journal of the European Academy of Dermatology and Venereology 31(8), pp. 1254-1259. (10.1111/jdv.14254)
• Szabo, C.et al. 2017. Attachment styles of dermatological patients in Europe: a multicenter study in 13 countries. Acta Dermato Venereologica 97, pp. 813-818. (10.2340/00015555-2619)
• Balieva, F.et al. 2017. The burden of common skin diseases assessed with the EQ5D: a European multicentre study in 13 countries. British Journal of Dermatology 176(5), pp. 1170-1178. (10.1111/bjd.15280)
• Finlay, A. 2017. Quimp: A word meaning "quality of life impairment". Acta Derm Venereol 97(4), pp. 546-547. (10.2340/00015555-2650)
• Finlay, A. Y. 2017. Every dermatology consultation: think adherence [Editorial]. British Journal of Dermatology 176(3), pp. 558-559. (10.1111/bjd.15250)
• Ali, F.et al. 2017. A systematic review of the use of quality-of-life instruments in randomised controlled trials of psoriasis. British Journal of Dermatology 176(3), pp. 577-593. (10.1111/bjd.14788)
• Finlay, A.et al. 2017. Why quality of life measurement is important in dermatology clinical practice An expert-based Opinion Statement by the EADV Task Force on Quality of Life. Journal of the European Academy of Dermatology and Venereology 31(3), pp. 424-431. (10.1111/jdv.13985)
• Harun, N. A.et al. 2017. Understanding clinician influences and patient perspectives on outpatient discharge decisions: a qualitative study. BMJ Open 7, article number: e010807. (10.1136/bmjopen-2015-010807)
• Salek, S.et al. 2017. The value of quality of life assessment in monitoring the efficacy of interventions in psoriasis and the role of minimal clinically important difference in interpretation of scores: a systematic review. International Journal of Clinical Pharmacy 39(1), pp. 238., article number: PE007. (10.1007/s11096-016-0404-4)
• Finlay, A. Y. 2017. Guest Editorial: How to Succeed in Medicine. The British Student Doctor Journal 1(1), pp. 4-6. (10.18573/j.2017.10119)
• Chernyshov, P. V.et al. 2017. Quality of life measurement in atopic dermatitis. Position paper of the European Academy of Dermatology and Venereology (EADV) task force on quality of life. Journal of the European Academy of Dermatology and Venereology 31(4), pp. 576-593. (10.1111/jdv.14058)
• Sampogna, F.et al. 2017. Impairment of sexual life in 3,485 dermatological outpatients from a multicentre study in 13 European countries. Acta Dermato-Venereologica 97(4), pp. 479-482. (10.2340/00015555-2561)

2016

• Greb, J. E.et al. 2016. Psoriasis. Nature Reviews Disease Primers 2, article number: 16082. (10.1038/nrdp.2016.82)
• Harun, N. A.et al. 2016. The development and clinical evaluation of a 'traffic-light' design dermatology outpatient discharge information checklist. British Journal of Dermatology 175(3), pp. 572-582. (10.1111/bjd.14650)
• Nast, A.et al. 2016. European evidence-based (S3) guideline for the treatment of acne - update 2016 - short version. Journal of the European Academy of Dermatology and Venereology 30(8), pp. 1261-1268. (10.1111/jdv.13776)
• Layton, A.et al. 2016. New patient-oriented tools for assessing atrophic acne scarring. Dermatology and Therapy 6(2), pp. 219-233. (10.1007/s13555-016-0098-5)
• Olsen, J. R.et al. 2016. Quality of life impact of childhood skin conditions measured using the Children's Dermatology Life Quality Index (CDLQI): a meta-analysis. British Journal of Dermatology 174(4), pp. 853-861. (10.1111/bjd.14361)
• Stull, D. E.et al. 2016. Assessing changes in chronic spontaneous/idiopathic urticaria: comparisons of patient-reported outcomes using latent growth modeling. Advances in Therapy 33(2), pp. 214-224. (10.1007/s12325-016-0282-0)

2015

• van Geel, M.et al. 2015. Comparison of the Dermatology Life Quality Index and the Children's Dermatology Life Quality Index in assessment of quality of life in patients with psoriasis aged 16-17 years. British Journal of Dermatology 174(1), pp. 152-157. (10.1111/bjd.14163)
• Finlay, A. Y., Salek, S. and Piguet, V. 2015. Measuring family impact of skin diseases: FDLQI and FROM-16. Acta Dermato-Venereologica 95(8), pp. 1036. (10.2340/00015555-2121)
• Finlay, A. Y. 2015. Measuring quality of dermatology care from the patient's perspective: how was it for you?. British Journal of Dermatology 173(4), pp. 884-885. (10.1111/bjd.14146)
• Harun, N. A.et al. 2015. Appropriate and inappropriate influences on outpatient discharge decision making in dermatology: a prospective qualitative study. British Journal of Dermatology 173(3), pp. 720-730. (10.1111/bjd.13946)
• Campbell, N.et al. 2015. Equivalence of electronic and paper-based patient-reported outcome measures. Quality of Life Research 24(8), pp. 1949-1961. (10.1007/s11136-015-0937-3)
• Finlay, A. Y.et al. 2015. How to CHAIR an academic session. British Journal of Dermatology 173(3), pp. 859-860. (10.1111/bjd.13738)
• Basra, M. K.et al. 2015. PFI-14©: A Rasch Analysis Refinement of the Psoriasis Family Index. Dermatology 231(1), pp. 15-23. (10.1159/000379748)
• Finlay, A. Y. 2015. Patient-reported outcome measures in psoriasis: assessing the assessments. British Journal of Dermatology 172(5), pp. 1178-1179. (10.1111/bjd.13775)
• Dalgard, F. J.et al. 2015. The psychological burden of skin diseases: a cross-sectional multicenter study among dermatological out-patients in 13 European countries. Journal of Investigative Dermatology 135(4), pp. 984-991. (10.1038/jid.2014.530)
• Olsen, J. R.et al. 2015. Time to resolution and effect on quality of life of molluscum contagiosum in children in the UK: a prospective community cohort study. Lancet Infectious Diseases 15(2), pp. 190-195. (10.1016/S1473-3099(14)71053-9)
• Basra, M.et al. 2015. Determining the minimal clinically important difference and responsiveness of the Dermatology Life Quality Index (DLQI): further data. Dermatology 230(1), pp. 27-33. (10.1159/000365390)

2014

• Bhatti, Z. U.et al. 2014. Chronic disease influences over 40 major life-changing decisions (MLCDs): a qualitative study in dermatology and general medicine. Journal of the European Academy of Dermatology and Venereology 28(10), pp. 1344-1355. (10.1111/jdv.12289)
• Harun, N. A.et al. 2014. The dermatology outpatient discharge decision: understanding a critical but neglected process. British Journal of Dermatology 170(5), pp. 1029-1038. (10.1111/bjd.12826)
• Golics, C. J.et al. 2014. The development and validation of the Family Reported Outcome Measure (FROM-16)© to assess the impact of disease on the partner or family member. Quality of Life Research 23(1), pp. 317-326. (10.1007/s11136-013-0457-y)
• Finlay, A. 2014. Quality of life in dermatology: after 125 years, time for more rigorous reporting. British Journal of Dermatology 170(1), pp. 4-6. (10.1111/bjd.12737)

2013

• Finlay, A. Y. 2013. The three dimensions of skin disease burden: 'now', 'long term' and 'family'[note]. British Journal of Dermatology 169(5), pp. 963-964. (10.1111/bjd.12640)
• Basra, M. K. A.et al. 2013. Infants' Dermatitis Quality of Life Index: a decade of experience of validation and clinical application. British Journal of Dermatology 169(4), pp. 760-768. (10.1111/bjd.12563)
• Golics, C. J.et al. 2013. The impact of disease on family members: a critical aspect of medical care. Journal of the Royal Society of Medicine 106(10), pp. 399-407. (10.1177/0141076812472616)
• Salek, M.et al. 2013. Clinical experience and psychometric properties of the Children's Dermatology Life Quality Index (CDLQI), 1995-2012. British Journal of Dermatology 169(4), pp. 734-759. (10.1111/bjd.12437)
• Dodington, S. R.et al. 2013. The Dermatitis Family Impact questionnaire: a review of its measurement properties and clinical application. British Journal of Dermatology 169(1), pp. 31-46. (10.1111/bjd.12232)
• Ingram, J. R.et al. 2013. Segmental cherry angiomas associated with extragenital lichen sclerosus: a report of two cases. Clinical and Experimental Dermatology 38(4), pp. 386-389. (10.1111/j.1365-2230.2012.04479.x)
• Bhatti, Z. U.et al. 2013. The development and validation of the major life changing decision profile (MLCDP). Health and Quality of Life Outcomes 11(1), article number: 78. (10.1186/1477-7525-11-78)
• Basra, M. K. A., Finlay, A. Y. and Salek, M. 2013. Development and validation of teenagers' Quality of Life (T-QoL(C)) index: A dermatology-specific measure for adolescents [Abstract]. Journal of Investigative Dermatology 133(S1), pp. S95. (10.1038/jid.2013.98)
• Basra, M. K. A., Salek, M. and Finlay, A. Y. 2013. Minimal Clinically Important Difference (MCID) of the Dermatology Life Quality Index (DLQI) scores and responsiveness to change in inflammatory dermatoses [Abstract]. Journal of Investigative Dermatology 133(S1), pp. S95. (10.1038/jid.2013.98)
• Golics, C. J.et al. 2013. The impact of patients' chronic disease on family quality of life: an experience from 26 specialties. International Journal of General Medicine 6, pp. 787-798. (10.2147/IJGM.S45156)
• Bhatti, Z. U., Salek, S. and Finlay, A. Y. 2013. Concept of major life-changing decisions in life course research. Current Problems in Dermatology -Basel- 44, pp. 52-66. (10.1159/000350389)
• Finlay, A. 2013. Put the student in charge: Take part in the biggest revolution ever in teaching and learning in dermatology. Acta Dermato-Venereologica 93(1), pp. 23-26. (10.2340/00015555-1427)

2012

• Finlay, A. Y.et al. 2012. Dermatology Life Quality Index (DLQI): A Paradigm Shift to Patient-Centered Outcomes [Letter]. Journal of Investigative Dermatology 132(10), pp. 2464-2465. (10.1038/jid.2012.147)
• Katugampola, R. P.et al. 2012. Congenital erythropoietic porphyria: A single-observer clinical study of 29 cases. British Journal Of Dermatology 167(4), pp. 901-913. (10.1111/j.1365-2133.2012.11160.x)
• Katugampola, R. P.et al. 2012. A management algorithm for congenital erythropoietic porphyria derived from a study of 29 cases. British Journal Of Dermatology 167(4), pp. 888-900. (10.1111/j.1365-2133.2012.11154.x)
• Basra, M. K. A.et al. 2012. EuroQol-5D (EQ-5D): its Use in Pharmacoeconomic Studies in Dermatology [Abstract]. Journal of Investigative Dermatology 132(S2), pp. S72. (10.1038/jid.2012.300)
• Basra, M. K. A.et al. 2012. The Dermatology Life Quality Index (DLQI) and EuroQol-5D (EQ-5D): is there a correlation between these two measures? [Abstract]. Journal of Investigative Dermatology 132(S2), pp. S72. (10.1038/jid.2012.300)
• Golics, C. J.et al. 2012. The Family Reported Outcome Measure (c): initial validation of a generic QoL measure for family members of patients with chronic medical conditions [Abstract]. Journal of Investigative Dermatology 132(S2), pp. S72. (10.1038/jid.2012.300)
• Pereira, F. R. A.et al. 2012. The Role of the EQ-5D in the Economic Evaluation of Dermatological Conditions and Therapies. Dermatology 225(1), pp. 45-53. (10.1159/000339865)
• Salek, M.et al. 2012. The clinical and non-clinical factors influencing discharge decisions in dermatology: is there a need for discharge strategy? [Abstract]. International Journal of Clinical Pharmacy 34(1), pp. 178-179. (10.1007/s11096-011-9602-2)

2011

• Finlay, A. Y.et al. 2011. Non-clinical influences on decision taking in dermatology clinics [Abstract]. Journal of Investigative Dermatology 131(S2), pp. S116-S117. (10.1038/jid.2011.216)
• Basra, M.et al. 2011. Refinement and Validation of Teenager's Quality of Life Questionnaire (T-QoL) [Abstract]. Journal of Investigative Dermatology 131(S2), pp. S50. (10.1038/jid.2011.214)
• Basra, M.et al. 2011. A Qualitative Investigation into the Factors Influencing Discharge Decisions in Dermatology [Abstract]. Journal of Investigative Dermatology 131(S2), pp. S50. (10.1038/jid.2011.214)
• Basra, M.et al. 2011. Application of Rasch Analysis to Psoriasis Family Index (PFI) - a Novel Psoriasis-Specific Quality of Life Instrument for Family Members and Partners of Psoriasis Patients [Abstract]. Journal of Investigative Dermatology 131(S2), pp. S49. (10.1038/jid.2011.214)
• Golics, C. J.et al. 2011. Diseases profoundly affect the Quality of Life of family members of patients [Abstract]. Journal of Investigative Dermatology 131(S2), pp. S39. (10.1038/jid.2011.214)
• Bhatti, Z. U., Salek, M. and Finlay, A. Y. 2011. Major life changing decisions and cumulative life course impairment [Letter]. Journal Of The European Academy Of Dermatology & Venereology 25(2), pp. 245-246. (10.1111/j.1468-3083.2010.03930.x)
• Bhatti, Z. U., Salek, M. and Finlay, A. Y. 2011. Chronic diseases influence major life changing decisions: a new domain in quality of life research. Journal of the Royal Society of Medicine 104(6), pp. 241-250. (10.1258/jrsm.2011.110010)
• Finlay, A. . Y.et al. 2011. Non-clinical influences in the dermatology consultation: the doctor's perspective and the challenge to evidence based practice [Abstract]. Acta Dermato-Venereologica 91(2), pp. 224-224.
• Bhatti, Z. U., Salek, M. and Finlay, A. Y. 2011. The influence of skin disease on major life changing decisions [Abstract]. Acta Dermato-Venereologica 91(2), pp. 221-222.
• Golics, C. J.et al. 2011. The impact of disease on the lives of family members [Abstract]. Acta Dermato-Venereologica 91(2), pp. 219-220.
• Basra, M. A. K.et al. 2011. Measuring skin disease in adolescence: bridging the gap in quality of life assessment [Abstract]. Acta Dermato-Venereologica 91(2), pp. 219-219.
• Bhatti, Z. U., Salek, M. and Finlay, A. Y. 2011. Development of the Major Life Changing Decisions Profile: a novel approach to measure the long-term impact of disease [Abstract]. British Journal of Dermatology 165(S1), pp. 52. (10.1111/j.1365-2133.2011.10277.x)

2010

• Hajjaj, F. M.et al. 2010. Nonclinical influences, beyond diagnosis and severity, on clinical decision making in dermatology: understanding the gap between guidelines and practice. British Journal of Dermatology 163(4), pp. 789-799. (10.1111/j.1365-2133.2010.09868.x)
• Bhatti, Z. U., Salek, M. and Finlay, A. Y. 2010. The influence of chronic skin diseases on major life-changing decisions as a parameter for the assessment of long-term impact [Abstract]. British Journal of Dermatology 163(S1), pp. 39-40. (10.1111/j.1365-2133.2010.09728.x)
• Hajjaj, F.et al. 2010. Nonclinical influences in dermatology decision making: a study of clinicians' perspective [Abstract]. British Journal of Dermatology 163(S1), pp. 44-45. (10.1111/j.1365-2133.2010.09728.x)
• Basra, M. K. A.et al. 2010. Strengthening the Dermatology Life Quality Index's clinical meaning: minimal clinically important difference of the scores [Abstract]. British Journal of Dermatology 163(S1), pp. 41-41. (10.1111/j.1365-2133.2010.09728.x)
• Hajjaj, F. M.et al. 2010. Non-clinical influences on clinical decision-making: a major challenge to evidence-based practice. Journal of the Royal Society of Medicine 103(5), pp. 178-187. (10.1258/jrsm.2010.100104)
• Salek, M.et al. 2010. Adolescents with skin diseases: the forgotten group [Abstract]. Pharmacy World and Science 32(2), pp. 240-241. (10.1007/s11096-010-9378-9)
• Salek, M.et al. 2010. Assessment of the clinical meaningfulness of change in dermatology life quality index scores [Abstract]. Pharmacy World and Science 32(2), pp. 236-236. (10.1007/s11096-010-9378-9)
• Hajjaj, F. M.et al. 2010. Clinical decision making in dermatology: observation of consultations and the patients' perspectives. Dermatology 221(4), pp. 331-341. (10.1159/000320124)

2009

• Golics, C. J.et al. 2009. Adolescents with skin disease have specific Quality of Life issues. Dermatology 218(4), pp. 357-366. (10.1159/000205524)
• Basra, M. K.et al. 2009. Dermatology Life Quality Index: measuring the change in scores and its clinical meaningfulness [Abstract]. Journal of Investigative Dermatology 129(S2), pp. S30. (10.1038/jid.2009.232)
• Bhatti, Z. U.et al. 2009. Chronic respiratory diseases strongly influence major life-changing decisions. Thorax 64(Supp.4), pp. A113., article number: P91. (10.1136/thx.2009.127159m)
• Bhatti, Z. U., Finlay, A. Y. and Salek, M. 2009. Chronic skin diseases influence major life-changing decisions: a new frontier in health outcome research [Abstract]. British Journal of Dermatology 161(S1), pp. 58-59.
• Hajjaj, F. M.et al. 2009. Nonclinical influences on clinical decision making in dermatology [Abstract]. British Journal of Dermatology 161(S1), pp. 59. (10.1111/j.1365-2133.2009.09126.x)
• Salek, M.et al. 2009. What are the health-related quality-of-life issues in adolescents with skin disease? Do they require special consideration [Abstract]. Pharmacy World & Science 31(2), pp. 328-329. (10.1007/s11096-008-9274-8)
• Smith, C.et al. 2009. British Association of Dermatologists' guidelines for biologic interventions for psoriasis 2009. British Journal of Dermatology 161(5), pp. 987-1019. (10.1111/j.1365-2133.2009.09505.x)
• Ingram, J. R., Martin, J. A. and Finlay, A. Y. 2009. Impact of topical calcineurin inhibitors on quality of life in patients with atopic dermatitis. American Journal of Clinical Dermatology 10(4), pp. 229-237. (10.2165/00128071-200910040-00003.)

2008

• Basra, M. K. A.et al. 2008. Measurement of family impact of skin disease: further validation of the Family Dermatology Life Quality Index (FDLQI). Journal of the European Academy of Dermatology and Venereology 22(7), pp. 813-821. (10.1111/j.1468-3083.2008.02593.x)
• Hajjaj, F. M.et al. 2008. Influences on clinical decision-making in dermatology outpatient clinics [Abstract]. British Journal of Dermatology 159(S1), pp. 49-50. (10.1111/j.1365-2133.2008.08538.x)
• Basra, M. K. A.et al. 2008. The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results. British Journal of Dermatology 159(5), pp. 997-1035. (10.1111/j.1365-2133.2008.08832.x)
• Hajjaj, F. M.et al. 2008. Clinical decision-making in dermatology: the role of clinical and non clinical factors [abstract]. Journal Of Investigative Dermatology 128(10), pp. 2550 -2550. (10.1038/jid.2008.267)
• Jong, C. T.et al. 2008. The quality of life of 790 patients with photodermatoses. British Journal of Dermatology 159(1), pp. 192-197. (10.1111/j.1365-2133.2008.08581.x)
• Davies, E.et al. 2008. Does ad hoc quality-of-life discussion in inflammatory skin disease consultations reflect standardized patient-reported outcomes?. Clinical and Experimental Dermatology 33(1), pp. 16-21. (10.1111/j.1365-2230.2007.02557.x)

2007

• Misery, L.et al. 2007. Atopic dermatitis: Impact on the quality of life of patients and their partners. Dermatology 215(2), pp. 123-129. (10.1159/000104263)
• Eghileb, A. M., Davies, E. E. G. and Finlay, A. Y. 2007. Psoriasis has a major secondary impact on the lives of family members and partners. British Journal of Dermatology 156(6), pp. 1245-1250. (10.1111/j.1365-2133.2007.07881.x)
• Katugampola, R. P., Lewis, V. J. and Finlay, A. Y. 2007. The Dermatology Life Quality Index: assessing the efficacy of biological therapies for psoriasis [review]. British Journal of Dermatology 156(5), pp. 945-950. (10.1111/j.1365-2133.2007.07817.x)
• Basra, M. K. and Finlay, A. Y. 2007. The family impact of skin diseases: the Greater Patient concept. British Journal of Dermatology 156(5), pp. 929-937. (10.1111/j.1365-2133.2007.07794.x)
• Basra, M. K., Sue-Ho, R. and Finlay, A. Y. 2007. The Family Dermatology Life Quality Index: measuring the secondary impact of skin disease. British Journal of Dermatology 156(3), pp. 528-538. (10.1111/j.1365-2133.2006.07617.x)
• Finlay, A. Y., Basra, M. K. A. and Sue-Ho, R. 2007. The Family Dermatology Life Quality Index: measuring the secondary impact of skin disease. British Journal of Dermatology 156(3), pp. 528-538. (10.1111/j.1365-2133.2006.07617.x)
• Salek, S.et al. 2007. Health related quality of life (HRQoL) discussion in consultations: a key to successful treatment outcomes. Pharmacy World & Science 29(5), pp. 454-455.
• Salek, S., Roberts, A. and Finlay, A. Y. 2007. The practical reality of using a patient-reported outcome measure in a routine dermatology clinic. Dermatology 215(4), pp. 315-319. (10.1159/000107625)

2006

• Dalgard, F. and Finlay, A. Y. 2006. Need and greed in dermatology: Disease and outcome measures in dermatological healthcare planning. Dermatology 213(4), pp. 279-283. (10.1159/000096190)
• Patel, G. K.et al. 2006. Imiquimod 5% cream monotherapy for cutaneous squamous cell carcinoma in situ (Bowen's disease): a randomized, double-blind, placebo-controlled trial. Journal of the American Academy of Dermatology 54(6), pp. 1025-1032. (10.1016/j.jaad.2006.01.055)
• Davies, E.et al. 2006. Quality of life discussion and patient satisfaction in inflammatory skin disease consultations [Abstract]. Journal of the American Academy of Dermatology 54(3S), pp. AB120. (10.1016/j.jaad.2005.11.493)
• Patel, G. K.et al. 2006. Numerous keratinocyte subtypes involved in wound re-epithelialization. Journal of Investigative Dermatology 126(2), pp. 497-502. (10.1038/sj.jid.5700101)
• Holme, S. A.et al. 2006. Erythropoietic protoporphyria in the United Kingdom: clinical features and effect on quality of life. British Journal of Dermatology 155(3), pp. 574-81. (10.1111/j.1365-2133.2006.07472.x)
• Holme, S. A.et al. 2006. Erythropoietic protoporphyria in the U.K.: clinical features and effect on quality of life. British Journal of Dermatology 155(3), pp. 574-581. (10.1111/j.1365-2133.2006.07472.x)

2005

• David, S. E.et al. 2005. Does enough quality of life-related discussion occur during dermatology outpatient consultations?. British Journal of Dermatology 153(5), pp. 997-1000. (10.1111/j.1365-2133.2005.06876.x)
• Hongbo, Y.et al. 2005. Translating the science of quality of life into practice: what do Dermatology Life Quality index scores mean?. British Journal of Dermatology 125(4), pp. 659-664. (10.1111/j.0022-202X.2005.23621.x)
• Katugampola, R.et al. 2005. Psoriasis decision taking and the dermatology life quality index bands [Abstract]. British Journal of Dermatology 153(2), pp. 475-476. (10.1111/j.1365-2133.2005.06872.x)
• Katugampola, R. P., Hongbo, Y. and Finlay, A. Y. 2005. Clinical management decisions are related to the impact of psoriasis on patient-rated quality of life. British Journal of Dermatology 152(6), pp. 1256-1262. (10.1111/j.1365-2133.2005.06576.x)
• Finlay, A. Y. 2005. Current severe psoriasis and the Rule of Tens. British Journal of Dermatology 152(5), pp. 861-867. (10.1111/j.1365-2133.2005.06502.x)
• Hongbo, Y.et al. 2005. Translating the science of quality of life into practice: what do Dermatology Life Quality Index scores mean?. Journal of Investigative Dermatology 125(4), pp. 659-664. (10.1111/j.0022-202X.2005.23621.x)
• Smith, C. H.et al. 2005. British Association of Dermatologists guidelines for use of biological interventions in psoriasis 2005. British Journal of Dermatology 153(3), pp. 486-497. (10.1111/j.1365-2133.2005.06893.x)
• Lewis, V. J. and Finlay, A. Y. 2005. Two decades experience of the Psoriasis Disability Index [review]. Dermatology 210(4), pp. 261-268. (10.1159/000084748)

2004

• Hongbo, Y.et al. 2004. Translating the science of quality of life into practice: what do Dermatology Life Quality Index scores mean? [Abstract]. British Journal of Dermatology 151(S68), pp. 45-46. (10.1111/j.1365-2133.2004.05948.x)
• Salek, M. S.et al. 2004. Quality of life improvement in treatment of psoriasis with intermittent short course cyclosporin (Neoral (R). Quality of Life Research 13, pp. 91-95.

2003

• Finlay, A. Y.et al. 2003. Hospitalization for severe skin disease improves quality of life in the United Kingdom and the United States: a comparative study. Journal of the American Academy of Dermatology 49(2), pp. 249-54. (10.1067/S0190-9622(03)00897-1)
• Holme, S. A.et al. 2003. The Children's Dermatology Life Quality Index: validation of the cartoon version. British Journal of Dermatology 148(2), pp. 285-290. (10.1046/j.1365-2133.2003.05157.x)
• Finlay, A. Y., Salek, M. and Haney, J. 2003. Intramuscular alefacept improves health-related quality of life in patients with chronic plaque psoriasis. Dermatology 206(4), pp. 307-315. (10.1159/000069942)

2002

• Hermansen, S. E., Helland, C. A. and Finlay, A. Y. 2002. Patients' and doctors' assessment of skin disease handicap. Clinical and Experimental Dermatology 27(3), pp. 249-250. (10.1046/j.1365-2230.2002.10263.x)

2001

• Finlay, A. Y. 2001. Quality of life in atopic dermatitis. Journal of the American Academy of Dermatology 45(1 Supp), pp. S64-S66.
• Williamson, D., Gonzalez, M. and Finlay, A. Y. 2001. The effect of hair loss on quality of life. Journal of the European Academy of Dermatology and Venereology 15(2), pp. 137-139. (10.1046/j.1468-3083.2001.00229.x)
• Chave, T. A., Finlay, A. Y. and Knight, A. G. 2001. Thalidomide usage in Wales: the need to follow guidelines. British Journal of Dermatology 144(2), pp. 310-315. (10.1046/j.1365-2133.2001.04020.x)
• Finlay, A. Y., Lewis-Jones, M. and Dykes, P. J. 2001. The Infant's Dermatitis Quality of Life Index. British Journal of Dermatology 144(1), pp. 104-110. (10.1046/j.1365-2133.2001.03960.x)
• Goodwin, R. G., Finlay, A. Y. and Anstey, A. V. 2001. Vitiligo following narrow-band TL-01 phototherapy for psoriasis [Letter]. British Journal of Dermatology 144(6), pp. 1264-1266. (10.1046/j.1365-2133.2001.04247.x)

2000

• Finlay, A. Y. 2000. Dowling Oration 2000. Dermatology patients: what do they really need?. Clinical and Experimental Dermatology 25(5), pp. 444-450. (10.1046/j.1365-2230.2000.00684.x)

1998

• Grosshans, E.et al. 1998. Evaluation of clinical efficacy and safety of adapalene 0.1% gel versus tretinoin 0.025% gel in the treatment of acne vulgaris, with particular reference to the onset of action and impact on quality of life. British Journal of Dermatology 139(sup 52), pp. 26-33. (10.1046/j.1365-2133.1998.1390s2026.x)

1997

• Salek, M., Finlay, A. Y. and Sumner, M. 1997. Long-term cyclosporin treatment improves quality of life in eczema [Abstract]. Quality of Life Research 6(7-8), article number: 334.
• Finlay, A. Y. 1997. Quality of life measurement in dermatology: a practical guide [review]. British Journal of Dermatology 136(3), pp. 305-314. (10.1046/j.1365-2133.1997.5541510.x)
• Salek, M., Finlay, A. Y. and Sumner, M. J. 1997. Impact of intermittent short course cyclosporin therapy on quality of life of patients with psoriasis [Abstract]. Quality of Life Research 6(7-8), article number: 335.

1996

• Finlay, A. Y. 1996. Measurement of disease activity and outcome in atopic dermatitis [review]. British Journal of Dermatology 135(4), pp. 509-515. (10.1046/j.1365-2133.1996.d01-1031.x)
• Blackford, S.et al. 1996. Basal cell carcinomas cause little handicap. Quality of Life Research 5(2), pp. 191-194.
• Salek, M., Khan, G. and Finlay, A. Y. 1996. Questionnaire techniques in assessing acne handicap: reliability and validity study. Quality of Life Research 5(1), pp. 131-138.
• Berth-Jones, J.et al. 1996. Cyclosporine in severe childhood atopic dermatitis: a multicenter study. Journal of the American Academy of Dermatology 34(6), pp. 1016-1021. (10.1016/S0190-9622(96)90281-9,)

1995

• Kurwa, H. A. and Finlay, A. Y. 1995. Dermatology in-patient management greatly improves life quality. British Journal of Dermatology 133(4), pp. 575-578. (10.1111/j.1365-2133.1995.tb02708.x)
• Finlay, A. . Y. and Coles, E. C. 1995. The effect of severe psoriasis on the quality of life of 369 patients. British Journal of Dermatology 132(2), pp. 236-244. (10.1111/j.1365-2133.1995.tb05019.x)

1994

• Finlay, A. Y. and Khan, G. K. 1994. Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use. Clinical and Experimental Dermatology 19(3), pp. 210-216. (10.1111/j.1365-2230.1994.tb01167.x)
• Finlay, A. Y. and Khan, G. K. 1994. Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use. Clinical and Experimental Dermatology 19(3), pp. 210-216. (10.1111/j.1365-2230.1994.tb01167.x)
• Finlay, A. Y. 1994. Global overview of Lamisil [Review]. British Journal of Dermatology 130(sup 43), pp. 1-3. (10.1111/j.1365-2133.1994.tb06082.x)

1993

• Long, C. C.et al. 1993. What do members of the National Eczema Society really want?. Clinical and Experimental Dermatology 18(6), pp. 516-522. (10.1111/j.1365-2230.1993.tb01020.x)
• Salek, M.et al. 1993. Cyclosporin greatly improves the quality of life of adults with severe atopic dermatitis. A randomized, double-blind, placebo-controlled trial. British Journal of Dermatology 129(4), pp. 422-430. (10.1111/j.1365-2133.1993.tb03170.x)
• Salek, M. S.et al. 1993. Cyclosporin greatly improves the quality of life of adults with severe atopic dermatitis. A randomized, double-blind, placebo-controlled trial.. British Journal of Dermatology 129(4), pp. 422-430. (10.1111/j.1365-2133.1993.tb03170.x)
• Buyse, L.et al. 1993. Collodion baby dehydration: the danger of high transepidermal water loss. British Journal of Dermatology 129(1), pp. 86-88. (10.1111/j.1365-2133.1993.tb03318.x)
• Rademaker, M.et al. 1993. Medical audit - need for a positive commitment. Clinical and Experimental Dermatology 18(1), pp. 17-20. (10.1111/j.1365-2230.1993.tb00958.x)

1991

• Sowden, J. M.et al. 1991. Double-blind, controlled, crossover study of cyclosporine in adults with severe refractory atopic-dermatitis. The Lancet 338(8760), pp. 137-140.

1990

• Finlay, A. Y.et al. 1990. Validation of Sickness Impact Profile and Psoriasis Disability Index in psoriasis. British Journal of Dermatology 123(6), pp. 751-756. (10.1111/j.1365-2133.1990.tb04192.x)

1989

• Salek, M.et al. 1989. Quality of life measurement in patients with psoriasis. Presented at: 18th European Symposium on Clinical Pharmacy, Nijmegen, Netherlands, 1989 Presented at Muller, N. F. and Hekster, Y. A. eds.Rational Use of Drugs: Proceedings of the 18th European Symposium on Clinical Pharmacy, Nijmegen, 1989. Progress in Clinical Pharmacy The Hague: Amsterdam Medical Press, SDU Publishers pp. 255-259.

1985

• Finlay, A. Y.et al. 1985. Antecubital fossa petechiae in Scottish country dancers [letter]. The Lancet 2(8465), pp. 1191-1191. (10.1016/s0140-6736(85)92716-3)